Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties: Endocrinology

Thyroglobulin measurement in monitoring response to radioiodine treatment in children with differentiated thyroid carcinoma (DTC) and lung metastases

Daria Handkiewicz-Junak, Jozef Roskosz, Jolanta Krajewska, Aleksandra Kukulska, Aleksandra Kropinska, Renata Deja, Zbigniew Puch and Barbara Jarzab
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 17P;
Daria Handkiewicz-Junak
1MSC Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jozef Roskosz
1MSC Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jolanta Krajewska
1MSC Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aleksandra Kukulska
1MSC Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aleksandra Kropinska
1MSC Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renata Deja
1MSC Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zbigniew Puch
1MSC Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Jarzab
1MSC Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

58

Objectives: Distant metastases, mainly to lung, are diagnosed in about 20% of children with DTC. Radioiodine (131-I) therapy is a treatment of choice in that case. Loss of radioiodine uptake, full radiological and biochemical recovery with thyroglobulin (Tg) serum level below cut-off level are expected to be documented to diagnose complete remission. The aim of the study was to evaluate Tg serum level response as a tool in follow-up of children with DTC and lung metastases treated by 131-I. Methods: From 235 children (age 4 to 18) diagnosed with DTC, 42 (17.9%) had lung metastases, in 40 cases 131-I-avid and only in 8 positive in radiological examinations. All were treated with 131-I (accumulated activities 100 to 950 mCi). To assess lung uptake and response, post-therapy WBS (95%) or diagnostic WBS (5%) was performed. Tg was evaluated either during TSH stimulation (cut-off at 10 ng/ml) or during T4 therapy causing TSH suppression (cut-off at 1 ng/ml). Tg results in patients with recovery (Tg rec) <70% were not studied. Results: Tg rec was <70% in 3 children (8%), so Tg results from 36 children were studied. The median Tg value at the diagnosis of metastases, measured at T4 withdrawal, was 175 ng/ml (in all but one > 10 ng/ml) and was significantly higher than in the group without lung dissemination (median 3.5 ng/ml). In children with 131-I avid metastases, after treatment, scintigraphic CR was achieved in all cases and radiological in 7 out of 8. After 131-I treatment, Tg serum level was decreasing in all children, however, it normalized at the last radioiodine treatment only in 13 (36%). During the follow-up Tg continued to decrease and the last stimulated Tg was below 10 ng/ml in 23 (64%) patients. The median time of follow-up was 75 months and did not differ between children with normal and elevated Tg concentration. Conclusions: Biochemical CR can be achieved in about 2/3 of children with DTC lung metastases but in most cases requires a long follow-up period. In a case of complete scintigraphic remission and decreasing Tg serum concentration careful follow-up but not further radioiodine therapy is indicated.

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 48, Issue supplement 2
May 1, 2007
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Thyroglobulin measurement in monitoring response to radioiodine treatment in children with differentiated thyroid carcinoma (DTC) and lung metastases
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Thyroglobulin measurement in monitoring response to radioiodine treatment in children with differentiated thyroid carcinoma (DTC) and lung metastases
Daria Handkiewicz-Junak, Jozef Roskosz, Jolanta Krajewska, Aleksandra Kukulska, Aleksandra Kropinska, Renata Deja, Zbigniew Puch, Barbara Jarzab
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 17P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Thyroglobulin measurement in monitoring response to radioiodine treatment in children with differentiated thyroid carcinoma (DTC) and lung metastases
Daria Handkiewicz-Junak, Jozef Roskosz, Jolanta Krajewska, Aleksandra Kukulska, Aleksandra Kropinska, Renata Deja, Zbigniew Puch, Barbara Jarzab
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 17P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties: Endocrinology

  • The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
  • Low dose I-123 MIBG diagnostic scan is inferior to I-131 MIBG post-treatment scan in detection of neuroblastoma
  • The correlation between salivary gland uptake in pre- and post-ablative 131I whole body scan and late salivary gland side effect after initial radioactive iodine therapy
Show more General Clinical Specialties: Endocrinology

Thyroid Cancer Updates II

  • Usefulness of 99mTc-pertechnetate SPECT (TSPECT) in remnant mass estimation of post surgical patients of differentiated thyroid cancer (DTC) during internal dosimetry
  • Radioiodide imaging and therapy of anaplastic thyroid cancer transfected with human sodium iodide symporter coupled with lentiviral system
  • Has come the day to do away with thyroid remnant ablation targeting 300 gray (Gy)?
Show more Thyroid Cancer Updates II

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire